Tap to start →
Photo: Ella Olsson / Unsplash
1 / 6
In December 2024, Zepbound became the first drug the FDA approved for obstructive sleep apnea.
2 / 6
Obstructive sleep apnea happens when the airway repeatedly narrows or closes during sleep.
3 / 6
Two 52-week trials tested tirzepatide in adults with obesity and moderate to severe sleep apnea, one in people not using PAP therapy and…
4 / 6
The FDA approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, alongside a reduced-calorie diet and…
5 / 6
Many people with sleep apnea don't know they have it.
6 / 6
Not automatically.
Why the FDA approved Zepbound for obstructive sleep apnea in adults with obesity, what SURMOUNT-OSA found, and how it fits with CPAP and insurance.
Tap below for the full page. Not medical advice; talk to your clinician about your care.